tetano
Editor, Senior Moderator
Pediatr Infect Dis J
. 2025 Feb 14.
doi: 10.1097/INF.0000000000004681. Online ahead of print. Characteristics of Children Hospitalized for Acute COVID-19 in France From February 2020 to December 2023
Alexis Rybak[SUP] 1 2 3 [/SUP], Naïm Ouldali[SUP] 1 2 4 5 [/SUP], Andreas Werner[SUP] 1 2 6 [/SUP], Paul Casha[SUP] 7 [/SUP], Blandine Robert[SUP] 8 [/SUP], Loïc de Pontual[SUP] 2 9 [/SUP], Stéphane Béchet[SUP] 1 [/SUP], Fabienne Cahn-Sellem[SUP] 6 [/SUP], François Angoulvant[SUP] 2 3 10 11 [/SUP], Robert Cohen[SUP] 1 2 12 13 [/SUP], Corinne Levy[SUP] 1 2 12 13 [/SUP]; PANDOR study group
Collaborators, Affiliations
We describe the characteristics of children hospitalized for coronavirus disease 2019 in France with a focus on the post-BA.1 Omicron period (February 2022-December 2023). We identified 3 main groups of children: those ≤90 days old (44.8%), older children with comorbidities (22.1%) and children with multisystem inflammatory syndrome (5.2%). Low vaccination coverage in these groups suggests that this burden could be alleviated with immunization.
. 2025 Feb 14.
doi: 10.1097/INF.0000000000004681. Online ahead of print. Characteristics of Children Hospitalized for Acute COVID-19 in France From February 2020 to December 2023
Alexis Rybak[SUP] 1 2 3 [/SUP], Naïm Ouldali[SUP] 1 2 4 5 [/SUP], Andreas Werner[SUP] 1 2 6 [/SUP], Paul Casha[SUP] 7 [/SUP], Blandine Robert[SUP] 8 [/SUP], Loïc de Pontual[SUP] 2 9 [/SUP], Stéphane Béchet[SUP] 1 [/SUP], Fabienne Cahn-Sellem[SUP] 6 [/SUP], François Angoulvant[SUP] 2 3 10 11 [/SUP], Robert Cohen[SUP] 1 2 12 13 [/SUP], Corinne Levy[SUP] 1 2 12 13 [/SUP]; PANDOR study group
Collaborators, Affiliations
- PMID: 39961110
- DOI: 10.1097/INF.0000000000004681
We describe the characteristics of children hospitalized for coronavirus disease 2019 in France with a focus on the post-BA.1 Omicron period (February 2022-December 2023). We identified 3 main groups of children: those ≤90 days old (44.8%), older children with comorbidities (22.1%) and children with multisystem inflammatory syndrome (5.2%). Low vaccination coverage in these groups suggests that this burden could be alleviated with immunization.